Covid-19 breath test startup Breathonix raising US$5m capital
Singapore
BREATHONIX, a Singapore-based startup which has gotten provisional authorisation locally for its Covid-19 breath test, is raising US$5 million in Series A funding to fuel its growth.
"At this stage now, we are growing very fast. We're expanding our team for commercialisation, so we're actively raising more funds," co-founder and chief operating officer Du Fang said during a Monday virtual press conference.
TRENDING NOW
Johor property old hand KSL readies family handover amid market boom
Seatrium eyes S$28 billion in project opportunities amid global race for energy security
China targets offshore billions in biggest crackdown in decades
Trek 2000 shares jump 26% after Osim founder Ron Sim drops claims, sells 7.3% stake to Azure Capital